A Phase 1, Study of BMF-500 in Adults With Acute Leukemia

Recruiting

Phase 1

A Phase 1, Study of BMF-500 in Adults With Acute LeukemiaA Phase 1, Study of BMF-500 in Adults With Acute Leukemia

Sponsor:

Biomea Fusion Inc.

Code:

NCT05918692

Conditions

Acute Myeloid Leukemia

Acute Lymphoblastic Leukemia

Acute Mixed-Phenotype Leukemia

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

BMF-500

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information